A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 17200 participants.
Also called NCT06642272
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 17,200 participants
- Sponsor
- Registry
-
NCT06642272
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT06642272. Randomized; no masking; primary purpose treatment. Start 2024-10-10 (actual); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
- Acronym
- APPLE TREE
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Heart Failure
- Condition
- Chronic Kidney Diseases
- Intervention (Drug)
- Empagliflozin 10 MG
- Intervention (Drug)
- Dapagliflozin 10 MG
- Lead sponsor
- Herlev and Gentofte Hospital
Record details
- Record id
cardio:ct-nct06642272- Content hash
e6e6c6edf86f2d84f0df62b09c9feb9ef7a5ff24c765351fa27f57756c4ecbb4